Niklas Gebauer, Axel Künstner, Julius Ketzer, Hanno M Witte, Tobias Rausch, Vladimir Benes, Jürgen Zimmermann, Judith Gebauer, Hartmut Merz, Veronica Bernard, Lana Harder, Katharina Ratjen, Stefan Gesk, Wolfgang Peter, Yannik Busch, Peter Trojok, Nikolas von Bubnoff, Harald Biersack, Hauke Busch, Alfred C Feller
Epstein-Barr virus (EBV)-associated diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS) constitute a distinct clinicopathological entity in the current World Health Organization (WHO) classification. However, its genomic features remain sparsely characterized. Here, we combine whole-genome sequencing (WGS), targeted amplicon sequencing (tNGS), and fluorescence in situ hybridization (FISH) from 47 EBV + DLBCL (NOS) cases to delineate the genomic landscape of this rare disease. Integrated WGS and tNGS analysis clearly distinguished this tumor type from EBV-negative DLBCL due to frequent mutations in ARID1A (45%), KMT2A/KMT2D (32/30%), ANKRD11 (32%), or NOTCH2 (32%)...
May 26, 2021: Blood Cancer Journal